One-Pot Synthesis of Pyrrole-Linked Bivalent Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing norBNI and related compounds have low yields, are not scalable, and produce toxic impurities and reaction by-products with undesirable pharmacological activity.
Innovation Solution
A one-pot synthesis process without solvent exchange or intermediate isolation, using polar solvents like DMF and catalysts such as methanesulfonic acid, which improves yield, cost, and scalability, and minimizes the production of toxic impurities, allowing for the production of high-purity norBNI through a simple recovery process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the traditional two-step Piloty synthesis method is used, then the synthesis process can be completed, but the yield is low (40-60%) and the process is not sufficiently scalable
Solution Approach 1:
The patent combines the two-step Piloty synthesis process into a single one-pot reaction. The first step (azine formation from naltrexone and hydrazine) and the second step (pyrrole formation) are merged into one continuous reaction sequence, eliminating the need for solvent exchange and intermediate isolation. This integration improves both yield (75-85%) and scalability while reducing process complexity.
Solution Approach 2:
The invention maintains continuous reaction conditions throughout the synthesis process. The reaction proceeds continuously from starting materials through intermediate formation to final product without interruption, solvent change, or intermediate isolation. This continuous action eliminates downtime and operational disruptions, thereby improving productivity and scalability.
2Quantity of substance
If the traditional synthesis method is used, then norBNI can be produced, but toxic impurities and reaction by-products with unintended pharmacological activity are generated
Solution Approach 1:
The patent eliminates the formation of toxic azine intermediates by taking them out of the reaction pathway. The one-pot synthesis directly converts naltrexone and hydrazine to norBNI through a rearrangement mechanism that bypasses stable azine intermediate formation. This extraction of harmful intermediates from the reaction sequence significantly reduces toxic impurities and by-products with unintended pharmacological activity.
Solution Approach 2:
The invention converts the potentially harmful azine intermediate into a beneficial transient species that immediately rearranges to form the desired pyrrole product. By controlling reaction conditions (acid catalyst, one-pot setup), the azine formation becomes a necessary step that leads directly to product formation rather than accumulating as a toxic by-product. This transforms a harmful intermediate into a useful reaction pathway.
3Productivity
If the traditional two-step process with solvent exchange is used, then the reaction can proceed, but the process complexity increases and yield decreases
Solution Approach 1:
The patent merges multiple operational steps (azine formation, solvent exchange, intermediate isolation, pyrrole formation) into a single one-pot reaction sequence. This consolidation eliminates the need for separate reaction vessels, filtration steps, and solvent exchanges, thereby reducing process complexity while simultaneously improving yield to 75-85%.
Solution Approach 2:
The single reaction vessel serves multiple functions: it acts as the reaction medium for azine formation, the solvent for the rearrangement reaction, and the medium for direct product isolation. This multi-functionality eliminates the need for multiple specialized equipment and operational steps, reducing process complexity while maintaining high productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves yields of 75% or greater, significantly reducing impurities and by-products, resulting in a highly pure norBNI product that is scalable for commercial production without the need for chromatography or chemical extraction.
Implementation Method 1
The reaction is conducted in the presence of a catalyst. For example, the catalyst can be an organic acid, an inorganic acid, or a combination thereof. In some embodiments, the catalyst comprises methanesulfonic acid (MeSO3H) and/or sulfuric acid.
Data Source
AI summary
The present invention in various aspects relates to the synthesis of pyrrole-linked bivalent compounds, including but not limited to norBNI, as well as pharmaceutical compositions comprising the same.